PharmaCyte Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2009
Market Capitalization	18	51	48	44	38	48	57	70	55	113	195	Upgrade
Market Cap Growth	-	5.50%	10.67%	16.31%	-21.44%	-15.56%	-19.76%	28.93%	-51.82%	-41.68%	333.22%	Upgrade
Enterprise Value	-43	-17	-37	41	37	47	55	67	53	111	191	Upgrade
PE Ratio	-1.64	-11.80	-11.39	-12.28	-9.80	-11.74	-8.28	-15.86	-9.01	-11.43	-7.14	Upgrade
PB Ratio	0.58	0.70	0.54	6.53	7.37	9.47	9.80	8.71	8.38	14.59	21.75	Upgrade
P/FCF Ratio	-8.96	-13.43	-11.73	-13.10	-16.04	-16.59	-11.13	-21.10	-12.57	-24.87	-125.11	Upgrade
P/OCF Ratio	-8.96	-13.43	-11.73	-13.10	-16.04	-16.59	-11.13	-21.10	-12.57	-24.87	-125.11	Upgrade
EV/EBITDA Ratio	37.17	3.96	8.76	-11.67	-9.59	-11.61	-8.12	-15.08	-8.70	-11.16	-7.01	Upgrade
EV/EBIT Ratio	37.17	3.96	8.76	-11.67	-9.59	-11.61	-8.12	-15.08	-8.70	-11.16	-7.01	Upgrade
EV/FCF Ratio	20.10	4.51	9.02	-12.44	-15.69	-16.41	-10.92	-20.06	-12.13	-24.28	-122.78	Upgrade
Debt / Equity Ratio	-	-	-	-	0.01	-	-	-	-	-	-	Upgrade
Debt / EBITDA Ratio	-	-	-	-	-0.02	-	-	-	-	-	-	Upgrade
Debt / FCF Ratio	-	-	-	-	-0.03	-	-	-	-	-	-	Upgrade
Quick Ratio	8.12	115.99	121.24	3.04	0.87	0.69	1.65	5.97	3.01	1.78	9.68	Upgrade
Current Ratio	8.16	116.18	121.38	3.14	1.01	0.88	1.99	6.10	3.19	2.74	11.20	Upgrade
Interest Coverage	-	-	-8327.41	-1164.87	-8446.88	-	-	-2886.38	-5090.34	-2009.47	-1364.23	Upgrade
Return on Equity (ROE)	-25.10%	-5.40%	-6.10%	-49.30%	-80.80%	-73.90%	-98.90%	-62.40%	-86.10%	-140.60%	-555.40%	Upgrade
Return on Assets (ROA)	-15.20%	-5.40%	-6.00%	-44.30%	-68.20%	-65.70%	-89.30%	-58.20%	-75.50%	-129.00%	-474.70%	Upgrade
Return on Capital (ROIC)	-19.47%	-8.88%	-4.88%	-54.24%	-74.10%	-81.37%	-121.02%	-54.93%	-93.11%	-170.51%	-212.24%	Upgrade
Earnings Yield	-63.23%	-8.47%	-8.78%	-8.14%	-10.20%	-8.52%	-12.08%	-6.31%	-11.10%	-8.75%	-14.01%	Upgrade
FCF Yield	-11.58%	-7.45%	-8.53%	-7.64%	-6.23%	-6.03%	-8.98%	-4.74%	-7.95%	-4.02%	-0.80%	Upgrade
Buyback Yield / Dilution	54.69%	-25.56%	-971.73%	-60.24%	-23.24%	-13.57%	-14.59%	-12.35%	-6.83%	-20.77%	-32.26%	Upgrade
Total Shareholder Return	54.69%	-25.56%	-971.73%	-60.24%	-23.24%	-13.57%	-14.59%	-12.35%	-6.83%	-20.77%	-32.26%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).